Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CinDome Pharma Logo
CinDome Pharma Growth Score
63
CB Rank
68446
Heat Score
52
CinDome Pharma provides treatment for the millions of people living with the devastating impact of chronic gastroparesis.
Founded
obfuscation
PrivateSeries B Cincinnati, Ohio, United States11-50 cindome.com/
Health Care
Medical
Overview

CinDome Pharma
Total Funding
obfuscation
Growth Score
63
Heat Score
52

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score63
-2 pts
in past quarter
Heat Score 52
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About CinDome Pharma

CB Rank
68446
CinDome Pharma provides treatment for the millions of people living with the devastating impact of chronic gastroparesis.
Founded
obfuscation
PrivateSeries B Cincinnati, Ohio, United States11-50 cindome.com/
Health Care
Medical

Funding Rounds

Series B
OBF
in
obfuscation
Series B
OBF
in
obfuscation

Details

Legal Name CinDome Pharma, Inc.
Operating Status Active
Company Type For Profit
About the Company
CinDome Pharma provides treatment for the millions of people living with the devastating impact of chronic gastroparesis.
Predictions & Insights

Growth Insight

See this Growth Insight
CinDome Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Deudomperidone (CIN-102)
An oral dopamine D2/D3 receptor antagonist developed to treat chronic gastroparesis by improving gastric emptying and reducing nausea and vomiting.

Research & Development

CinDome Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B
obfuscation
Series B - CinDome Pharma Logo
Series B - CinDome Pharma
2
obfuscation
— Series B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Mar 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 4, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

66
-82.74%
 in past month

IT Spend

$99KThis year, CinDome Pharma is projected to spend $99K on IT, according to Aberdeen.

Active Website Tech Count

13CinDome Pharma is actively using 13 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

10The intellectual property of CinDome Pharma includes 10 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is CinDome Pharma's headquarters? CinDome Pharma is located in Cincinnati, Ohio, United States.Who invested in CinDome Pharma? CinDome Pharma has 2 investors including CinRx Pharma and  Perceptive Advisors.When was the last funding round for CinDome Pharma? CinDome Pharma closed its last funding round on
obfuscation
from a Series B round.Who are CinDome Pharma's competitors? Alternatives and possible competitors to CinDome Pharma may include Sanofi, Takeda, and  Teva Pharmaceuticals.How much funding has CinDome Pharma raised to date? CinDome Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ba91958 1)
|